Andrew Moore
Global General Manager, Pfizer CentreOne
Ensuring Pfizer CentreOne continues to execute and deliver vital medicines for partners and their patients, Moore’s first year at Pfizer CentreOne saw him navigate the company through sweeping change forced by the pandemic. Under his leadership, the company now has a new toolkit and a new mindset when it comes to development and manufacturing.
Since joining Pfizer Centre in 2020, Moore has spearheaded the CDMO’s growth in the contract manufacturing sector with a focus on leveraging Pfizer’s development and manufacturing capabilities in small molecule API, large molecule biologics, sterile injectables and oral solids. Additionally, he has cemented the organization's position as a leading supplier.
We asked…
What was the most serendipitous moment in your career?
The transition from the armed forces to corporate America was one of the most impactful periods in my life. The first morning I woke up after leaving the military, the hardest decision of the day was deciding what tie to wear. That was a major departure from what I was used to. I knew the battlefield had changed for me and I was living in a whole new world. Transitioning from one skill set to another, and the ability to transform that into business strategies and execution, was surprisingly easy because the skills I learned prepared me in a way I will always be grateful for.
